OCRX - Ocera Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.79
0.00 (0.00%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close1.79
Open1.76
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.76 - 1.85
52 Week Range0.52 - 2.95
Volume969,372
Avg. Volume610,765
Market Cap47.46M
Beta1.37
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Want To Invest In Ocera Therapeutics Inc (undefined:OCRX)? Here’s How It Performed Lately
    Simply Wall St.3 days ago

    Want To Invest In Ocera Therapeutics Inc (undefined:OCRX)? Here’s How It Performed Lately

    For investors with a long-term horizon, assessing earnings trend over time and against industry benchmarks is more valuable than looking at a single earnings announcement in one point in time.Read More...

  • At $1.75, Is It Time To Buy Ocera Therapeutics Inc (OCRX)?
    Simply Wall St.28 days ago

    At $1.75, Is It Time To Buy Ocera Therapeutics Inc (OCRX)?

    Ocera Therapeutics Inc (NASDAQ:OCRX), a pharmaceuticals company based in United States, saw a significant share price rise of over 20% in the past couple of months on the NasdaqCM. LessRead More...

  • MarketWatchlast month

    Mallinckrodt will buy biotech Ocera Therapeutics for about $42 mln

    Mallinckrodt PLC will buy Ocera Therapeutics Inc. , including its mid-stage hepatic encephalopathy product, for about $42 million, the company said early Thursday. The deal also includes up to $75 million ...

  • Will Ocera Therapeutics Inc (OCRX) Need To Raise More Money?
    Simply Wall St.2 months ago

    Will Ocera Therapeutics Inc (OCRX) Need To Raise More Money?

    As the USD $26.51M market cap Ocera Therapeutics Inc (NASDAQ:OCRX) released another year of negative earnings, investors may be on edge waiting for breakeven. A crucial question to bear inRead More...

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of OCRX earnings conference call or presentation 9-May-17 8:30pm GMT

    Q1 2017 Ocera Therapeutics Inc Earnings Call

  • Capital Cube7 months ago

    ETFs with exposure to Ocera Therapeutics, Inc. : May 3, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ocera Therapeutics, Inc. Here are 5 ETFs with the largest exposure to OCRX-US. Comparing the performance and risk of Ocera Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube8 months ago

    ETFs with exposure to Ocera Therapeutics, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ocera Therapeutics, Inc. Here are 5 ETFs with the largest exposure to OCRX-US. Comparing the performance and risk of Ocera Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube9 months ago

    ETFs with exposure to Ocera Therapeutics, Inc. : March 27, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Ocera Therapeutics, Inc. Here are 5 ETFs with the largest exposure to OCRX-US. Comparing the performance and risk of Ocera Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Ocera Therapeutics, Inc. :OCRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube9 months ago

    Ocera Therapeutics, Inc. :OCRX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis Ocera Therapeutics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Ocera Therapeutics, Inc. – Intercept Pharmaceuticals, Inc., Evoke Pharma, Inc., SciClone Pharmaceuticals, Inc., Conatus Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated and Enanta Pharmaceuticals, Inc. (ICPT-US, EVOK-US, SCLN-US, CNAT-US, VRTX-US ... Read more (Read more...)

  • Ocera Therapeutics, Inc. :OCRX-US: Earnings Analysis: 2016 By the Numbers : March 16, 2017
    Capital Cube9 months ago

    Ocera Therapeutics, Inc. :OCRX-US: Earnings Analysis: 2016 By the Numbers : March 16, 2017

    Categories: Yahoo Finance Get free summary analysis Ocera Therapeutics, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Ocera Therapeutics, Inc. – Intercept Pharmaceuticals, Inc., Evoke Pharma, Inc., SciClone Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated and Enanta Pharmaceuticals, Inc. (ICPT-US, EVOK-US, SCLN-US, VRTX-US and ENTA-US) that have ... Read more (Read more...)

  • Here’s What’s Moving Immunomedics, Inc. (IMMU) And Ocera Therapeutics Inc (OCRX)
    Insider Monkey9 months ago

    Here’s What’s Moving Immunomedics, Inc. (IMMU) And Ocera Therapeutics Inc (OCRX)

    Yet again we’ve had a pretty busy week in the biotech space. Macro forces are coming in to play, and combined with what proved a busy release calendar, really moved a number of companies in the sector. Here are two end-of-the-week biotech movers, with a look at what’s driving the action in each, and where […]

  • Five Penny Stocks to Buy Now
    Insider Monkey9 months ago

    Five Penny Stocks to Buy Now

    Penny stocks are very risky to invest in, mainly due to the fact that many of these companies are trading over the counter and usually don’t provide a lot of information to investors. However, there are also stocks that are priced below $1 per share trading on bigger exchanges and there could be a number […]

  • Capital Cube11 months ago

    ETFs with exposure to Ocera Therapeutics, Inc. : January 19, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Ocera Therapeutics, Inc. Here are 5 ETFs with the largest exposure to OCRX-US. Comparing the performance and risk of Ocera Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Ocera Therapeutics (OCRX) Catches Eye: Stock Jumps 6.8%
    Zackslast year

    Ocera Therapeutics (OCRX) Catches Eye: Stock Jumps 6.8%

    Ocera Therapeutics (OCRX) saw its shares rise almost 7% in the last trading session.

  • How Cenveo, Inc. (CVO) Stacks Up Against Its Peers
    Insider Monkeylast year

    How Cenveo, Inc. (CVO) Stacks Up Against Its Peers

    At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […]